ExploreWatchlistsPricing
  1. JP-listed companies
  2. Linical Co., Ltd.
  3. Financials
  4. Revenue

Linical Co., Ltd. (2183)

Market cap
¥5.3B
P/E ratio
26.7x
Linical helps pharmaceutical companies develop and launch new drugs by providing clinical trial services, post-market safety monitoring, and drug discovery support.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue (Million JPY)YoY (%)
Mar 31, 20268,665-16.98%
Mar 31, 202510,437-15.20%
Mar 31, 202412,308-1.67%
Mar 31, 202312,517+8.32%
Mar 31, 202211,555+12.41%
Mar 31, 202110,279-6.00%
Mar 31, 202010,935-3.34%
Mar 31, 201911,313+24.14%
Mar 31, 20189,113+9.06%
Mar 31, 20178,356+8.99%
Mar 31, 20167,667+57.36%
Mar 31, 20154,872+30.90%
Mar 31, 20143,722+3.41%
Mar 31, 20133,599+15.72%
Mar 31, 20123,110

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat